
InnoCare Pharma Investor Relations Material
Latest events

Q4 2024
InnoCare Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from InnoCare Pharma Limited
Access all reports
InnoCare Pharma Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for cancer and autoimmune diseases. The company leverages its research and development capabilities to advance targeted therapies, including small molecules and biologics. InnoCare’s pipeline includes investigational treatments addressing hematologic malignancies, solid tumors, and chronic immune-related conditions. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Key slides for InnoCare Pharma Limited


R&D Day 2024
InnoCare Pharma Limited


H1 2024
InnoCare Pharma Limited
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
9969
Country
🇭🇰 Hong Kong